Barbanoj MJ - Search Results

1

Noradrenergic stimulation enhances human action monitoring.

Riba J, Rodríguez-Fornells A, Morte A, Münte TF, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. J Neurosci. 2005 Apr 27;25(17):4370-4. doi: 10.1523/JNEUROSCI.4437-04.2005. J Neurosci. 2005. PMID: 15858063 Free PMC article. Clinical Trial.

2

A neurophysiological study of the detrimental effects of alprazolam on human action monitoring.

Riba J, Rodríguez-Fornells A, Münte TF, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. Brain Res Cogn Brain Res. 2005 Oct;25(2):554-65. doi: 10.1016/j.cogbrainres.2005.08.009. Epub 2005 Sep 15. Brain Res Cogn Brain Res. 2005. PMID: 16168630 Clinical Trial.

3

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.

Riba J, Anderer P, Morte A, Urbano G, Jané F, Saletu B, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. Br J Clin Pharmacol. 2002 Jun;53(6):613-28. doi: 10.1046/j.1365-2125.2002.01609.x. Br J Clin Pharmacol. 2002. PMID: 12047486 Free PMC article. Clinical Trial.

4

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.

Riba J, Rodríguez-Fornells A, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. Psychopharmacology (Berl). 2002 Dec;165(1):18-28. doi: 10.1007/s00213-002-1237-5. Epub 2002 Oct 12. Psychopharmacology (Berl). 2002. PMID: 12474114 Clinical Trial.

5

Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.

Riba J, Anderer P, Jané F, Saletu B, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. Neuropsychobiology. 2004;50(1):89-101. doi: 10.1159/000077946. Neuropsychobiology. 2004. PMID: 15179026 Clinical Trial.

6

Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.

Barbanoj MJ, García-Gea C, Morte A, Izquierdo I, Pérez I, Jané F. Barbanoj MJ, et al. Neuropsychobiology. 2004;50(4):311-21. doi: 10.1159/000080959. Neuropsychobiology. 2004. PMID: 15539863 Clinical Trial.

7

Bringing ayahuasca to the clinical research laboratory.

Riba J, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. J Psychoactive Drugs. 2005 Jun;37(2):219-30. doi: 10.1080/02791072.2005.10399804. J Psychoactive Drugs. 2005. PMID: 16149336 Review.

8

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

Riba J, Romero S, Grasa E, Mena E, Carrió I, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. Psychopharmacology (Berl). 2006 May;186(1):93-8. doi: 10.1007/s00213-006-0358-7. Epub 2006 Mar 31. Psychopharmacology (Berl). 2006. PMID: 16575552 Free article. Clinical Trial.

9

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. Psychopharmacology (Berl). 2001 Feb;154(1):85-95. doi: 10.1007/s002130000606. Psychopharmacology (Berl). 2001. PMID: 11292011 Clinical Trial.

10

Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Barbanoj MJ. Riba J, et al. Among authors: barbanoj mj. Psychopharmacology (Berl). 2001 Oct;157(4):358-67. doi: 10.1007/s002130100816. Psychopharmacology (Berl). 2001. PMID: 11605094 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters